MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Sex Differences for Tau Association with Cognition in Early Parkinson’s Disease

    E. Bayram, A. Tsai, K. Wang, I. Litvan (La Jolla, USA)

    Objective: To assess sex differences for cerebrospinal fluid (CSF) phosphorylated tau (p-tau) association with cognition in Parkinson’s disease (PD) Background: Tau biomarkers can predict cognitive…
  • 2022 International Congress

    Lewy body disease clinical subgroups present similar disease progression rates

    C. Abdelnour, C. Young, E. Müller-Oehring, D. Ferreira, M. Shahid, M. Plastini, J. Winer, K. Poston (Stanford, USA)

    Objective: To characterize LBD clinical subgroups and identify possible differences in disease progression. Background: Patients with Lewy body disease (LBD) present a wide variety of…
  • 2022 International Congress

    LIG1 polymorphism modifies the age at onset in patients with Spinocerebellar Ataxia type 2

    LE. Almaguer-Mederos, D. Cuello-Almarales, R. Aguilera-Rodríguez, D. Almaguer-Gotay, Y. González-Zaldívar, R. Lamas-González, S. Gispert, G. Auburger (Holguin, Cuba)

    Objective: Assessing the role of LIG1 Exon 6 A→C polymorphism acting as a modifier of clinical severity in patients with Spinocerebellar ataxia type 2 (SCA2).…
  • 2022 International Congress

    Time-to-event approach mitigates the treatment masking effect of symptomatics on MDS-UPDRS Part III

    S. Zanigni, N. Shariati, T. Simuni, N. Pavese, K. Marek, R. Postuma, A. Monnet, E. Moore, A. Hahn, E. Davies, N. Pross, D. Trundell, T. Nikolcheva, G. Pagano (Basel, Switzerland)

    Objective: To assess whether a time-to-event (TTE) approach may mitigate the masking effect of changing symptomatic therapy on Movement Disorders Society–Unified Parkinson’s Disease (PD) Rating…
  • 2022 International Congress

    Local Field Potential Recordings in Parkinson’s Disease at Home: A Case Series Report

    K. Martinez, V. Madrigal, N. Morelli, A. Singer (Aliso Viejo, USA)

    Objective: To report novel, real-world use of chronic local field potential (LFP) sensing in patients with Parkinson’s disease (PD) outside-of-clinic settings. Background: Recent advancements in…
  • 2022 International Congress

    ADS024 attenuates striatal dopamine loss and restores movement in animal models of Parkinson’s disease

    L. Chesnel, S. Acton (Concord, USA)

    Objective: To evaluate the effect of ADS024, an oral single strain live biotherapeutic product (SS-LBP), on the pathophysiology of MPTP-induced Parkinson’s Disease (PD) phenotypes in…
  • 2022 International Congress

    Improvement of movement disorder and neurodevelopment under selegiline in a CLTC deficient patient

    F. Nardecchia, L. Pannone, F. Manti, V. Muto, R. Bove, L. Pollini, M. Giannini, M. Tartaglia, S. Martinelli, V. Leuzzi (Rome, Italy)

    Objective: We report the significative improvement on both movement disorder and neurodevelopment in a 5-year-old CLTC deficient patient treated with selegiline. Background: In 2019 we described a 30-year-old woman…
  • 2022 International Congress

    DaxibotulinumtoxinA for Injection in Adults With Upper Limb Spasticity After Stroke or Traumatic Brain Injury: A Randomized Placebo-Controlled Study (JUNIPER)

    A. Patel, M. Munin, Z. Ayyoub, G. Francisco, T. Gross, R. Rubio, J. Kesslak (Lee's Summit, USA)

    Objective: To evaluate the efficacy and safety of 3 doses of DaxibotulinumtoxinA for Injection (DAXI) vs placebo for adults with upper limb spasticity (ULS) after…
  • 2022 International Congress

    Dual target deep brain stimulation for clinically complex tremor disorders: a single centre prospective study

    R. Heartshorne, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

    Objective: We present a case series of patients with refractory complex tremor treated  with dual targeting DBS of ViM and pSTN/cZI. Background: The ventral intermediate (ViM) nucleus…
  • 2022 International Congress

    Survival and progression in GBA-associated dementia with Lewy bodies

    T. Shiner, A. Mirelman, Y. Piura, A. Migirov Sandrovitz, L. Raif, S. Korenblum, O. Goldstein, G. Kave, M. Gana Weisz, A. Bar Shira, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)

    Objective: To assess the impact of GBA mutations and APOE polymorphisms on progression and survival in a cohort of Ashkenazi Jewish (AJ) patients with DLB.…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley